<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A number of <z:chebi fb="65" ids="25512">neurotransmitters</z:chebi>, including <z:chebi fb="9" ids="15355">acetylcholine</z:chebi>, <z:chebi fb="19" ids="28790">serotonin</z:chebi>, <z:chebi fb="15" ids="33569">noradrenaline</z:chebi>, and <z:chebi fb="40" ids="18243">dopamine</z:chebi>, modulate cerebral perfusion </plain></SENT>
<SENT sid="1" pm="."><plain>In vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, reductions in markers of cholinergic innervation are consistently reported, and there are some indications that the serotonergic and dopaminergic systems may also be affected </plain></SENT>
<SENT sid="2" pm="."><plain>Limited data indicate that the numbers of nucleus basalis, locus coeruleus, and dorsal raph√© neurons and the density of neurotransmitter receptors are not reduced in the majority of cases </plain></SENT>
<SENT sid="3" pm="."><plain>These data suggest neurotransmitter systems as a potential therapeutic target in vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>